Meta Biomed Co. Ltd Total Liabilities
Meta Biomed Co. Ltd total liabilities. Based on the latest financial reports, Meta Biomed Co. Ltd (059210) has total liabilities worth ₩58.87 Billion KRW (≈ $39.90 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 059210 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Meta Biomed Co. Ltd (2011–2024)
Total liabilities of Meta Biomed Co. Ltd from 2011 to 2024. This chart illustrates how Meta Biomed Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 059210 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Meta Biomed Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Meta Biomed Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WithTech Inc.
KQ:348350
|
Korea | ₩21.51 Billion |
|
Hankook Cosmet
KO:123690
|
Korea | ₩25.67 Billion |
|
Mofast AB
ST:MOFAST
|
Sweden | Skr1.53 Billion |
|
Fy Grp Ltd
TW:6807
|
Taiwan | NT$1.05 Billion |
|
Techbond Group Bhd
KLSE:5289
|
Malaysia | RM35.55 Million |
|
Nahar Industrial Enterprises Limited
NSE:NAHARINDUS
|
India | Rs6.90 Billion |
|
Choong Ang Vaccine Laboratory Co. Ltd
KQ:072020
|
Korea | ₩17.40 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Meta Biomed Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Meta Biomed Co. Ltd asset portfolio.
Liquidity & Leverage Metrics
Meta Biomed Co. Ltd Total Liabilities Ratios Explained
Meta Biomed Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Meta Biomed Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Meta Biomed Co. Ltd (2011–2024)
The table below shows the annual total liabilities of Meta Biomed Co. Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩83.96 Billion ≈ $56.90 Million |
+46.11% |
| 2023-12-31 | ₩57.46 Billion ≈ $38.94 Million |
-4.99% |
| 2022-12-31 | ₩60.48 Billion ≈ $40.99 Million |
+34.99% |
| 2021-12-31 | ₩44.80 Billion ≈ $30.36 Million |
-25.17% |
| 2020-12-31 | ₩59.88 Billion ≈ $40.58 Million |
+19.70% |
| 2019-12-31 | ₩50.02 Billion ≈ $33.90 Million |
+4.82% |
| 2018-12-31 | ₩47.72 Billion ≈ $32.34 Million |
-35.21% |
| 2017-12-31 | ₩73.65 Billion ≈ $49.91 Million |
+7.54% |
| 2016-12-31 | ₩68.49 Billion ≈ $46.41 Million |
+8.86% |
| 2015-12-31 | ₩62.91 Billion ≈ $42.64 Million |
-11.21% |
| 2014-12-31 | ₩70.85 Billion ≈ $48.02 Million |
-1.93% |
| 2013-12-31 | ₩72.25 Billion ≈ $48.96 Million |
+15.52% |
| 2012-12-31 | ₩62.54 Billion ≈ $42.39 Million |
+321.41% |
| 2011-12-31 | ₩14.84 Billion ≈ $10.06 Million |
-- |
About Meta Biomed Co. Ltd
Meta Biomed Co., Ltd. engages in the research and development, production, and marketing of dental and surgical materials in South Korea and internationally. The company's dental products include endodontics, endodontic materials, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics; bone product… Read more